Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Calvo

Showing results (1-10 of 174) with videos related to

Pageof 18
Sort By:
Journal of Cellular Biochemistry|October 3, 2003
ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytesEleonora Pagano, Juan Carlos Calvo
Journal of Sport Rehabilitation|June 29, 2018
Exercises in Motor Development Positions. What Happens With the Activity of Antagonist Muscle Pairs? Pilot StudyEsther Casas, Arturo Justes, Carlos Calvo
Journal of Translational Medicine|July 14, 2025
Advancing prostate cancer research: an exploration of periprostatic adipose stem cellsPaula Alejandra Sacca, Juan Carlos Calvo
Frontiers in Endocrinology|May 2, 2022
Periprostatic Adipose Tissue Microenvironment: Metabolic and Hormonal Pathways During Prostate Cancer ProgressionPaula Alejandra Sacca, Juan Carlos Calvo
Journal of Cellular Biochemistry|November 9, 2007
Down-modulation of erbB2 activity is necessary but not enough in the differentiation of 3T3-L1 preadipocytesEleonora Pagano, Omar Coso, Juan Carlos Calvo
Biology of Reproduction|January 21, 2003
Effect of leptin on progesterone, human chorionic gonadotropin, and interleukin-6 secretion by human term trophoblast cells in culturePaula Cameo, Paul Bischof, Juan Carlos Calvo
Molecular Medicine Reports|July 2, 2011
Expression of erythroblastic leukemia viral oncogene homolog (erbBS) mRNAs and possible splice variants in 3T3-L1 preadipocytesEleonora Pagano, Vanina Fontana, Juan Carlos Calvo
American Journal of Hypertension|February 8, 2006
Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT StudyGerard London, Rolland Schmieder, Carlos Calvo, et al.
Therapeutics and Clinical Risk Management|March 25, 2008
Optimal timing for antihypertensive dosing: focus on valsartanRamón C Hermida, Diana E Ayala, Carlos Calvo
Journal of Hypertension|July 20, 2002
Angiotensin II type 1 receptor blocker irbesartan ameliorates vascular function in spontaneously hypertensive rats regardless of oestrogen statusAlberto Riveiro, Alejandro Mosquera, Manuela Alonso, et al.
Pageof 18

Showing results (1-10 of 174) with videos related to

Sort By:
Pageof 18
Journal of Cellular Biochemistry|October 3, 2003
ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytesEleonora Pagano, Juan Carlos Calvo
Journal of Sport Rehabilitation|June 29, 2018
Exercises in Motor Development Positions. What Happens With the Activity of Antagonist Muscle Pairs? Pilot StudyEsther Casas, Arturo Justes, Carlos Calvo
Journal of Translational Medicine|July 14, 2025
Advancing prostate cancer research: an exploration of periprostatic adipose stem cellsPaula Alejandra Sacca, Juan Carlos Calvo
Frontiers in Endocrinology|May 2, 2022
Periprostatic Adipose Tissue Microenvironment: Metabolic and Hormonal Pathways During Prostate Cancer ProgressionPaula Alejandra Sacca, Juan Carlos Calvo
Journal of Cellular Biochemistry|November 9, 2007
Down-modulation of erbB2 activity is necessary but not enough in the differentiation of 3T3-L1 preadipocytesEleonora Pagano, Omar Coso, Juan Carlos Calvo
Biology of Reproduction|January 21, 2003
Effect of leptin on progesterone, human chorionic gonadotropin, and interleukin-6 secretion by human term trophoblast cells in culturePaula Cameo, Paul Bischof, Juan Carlos Calvo
Molecular Medicine Reports|July 2, 2011
Expression of erythroblastic leukemia viral oncogene homolog (erbBS) mRNAs and possible splice variants in 3T3-L1 preadipocytesEleonora Pagano, Vanina Fontana, Juan Carlos Calvo
American Journal of Hypertension|February 8, 2006
Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT StudyGerard London, Rolland Schmieder, Carlos Calvo, et al.
Therapeutics and Clinical Risk Management|March 25, 2008
Optimal timing for antihypertensive dosing: focus on valsartanRamón C Hermida, Diana E Ayala, Carlos Calvo
Journal of Hypertension|July 20, 2002
Angiotensin II type 1 receptor blocker irbesartan ameliorates vascular function in spontaneously hypertensive rats regardless of oestrogen statusAlberto Riveiro, Alejandro Mosquera, Manuela Alonso, et al.
Pageof 18